Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
52
ATYR Quote, Financials, Valuation and Earnings
Last price:
$0.83
Seasonality move
:
-2.14%
Day range:
$0.75 - $0.86
52-week range:
$0.64 - $7.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
388.29x
P/B ratio:
1.01x
Volume:
3.2M
Avg. volume:
3.5M
1-year change:
-75.14%
Market cap:
$81.1M
Revenue:
$235K
EPS (TTM):
-$0.83
Analysts' Opinion
-
Consensus RatingaTyr Pharma, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $4.36, aTyr Pharma, Inc. has an estimated upside of 426.35% from its current price of $0.83.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.00 representing 100% downside risk from its current price of $0.83.
Fair Value
-
According to the consensus of 8 analysts, aTyr Pharma, Inc. has 426.35% upside to fair value with a price target of $4.36 per share.
ATYR vs. S&P 500
-
Over the past 5 trading days, aTyr Pharma, Inc. has overperformed the S&P 500 by 8.05% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
aTyr Pharma, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
aTyr Pharma, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter aTyr Pharma, Inc. reported revenues of $190K.
Earnings Growth
-
aTyr Pharma, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter aTyr Pharma, Inc. reported earnings per share of -$0.27.
Enterprise value:
3.1M
EV / Invested capital:
0.03x
Price / LTM sales:
388.29x
EV / EBIT:
--
EV / Revenue:
16.21x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.05x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$1.1M
Return On Assets:
-75.87%
Net Income Margin (TTM):
-39540.53%
Return On Equity:
-103.05%
Return On Invested Capital:
-87.48%
Operating Margin:
-14076.32%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $10.7M | $235K | $190K | -- | $190K | |
| Gross Profit | $7.7M | -$1.7M | -$1.1M | -$388K | -$199K | |
| Operating Income | -$46.9M | -$68.1M | -$78.7M | -$18.1M | -$26.7M | |
| EBITDA | -$43.9M | -$66.1M | -$77.3M | -$17.8M | -$26.4M | |
| Diluted EPS | -$0.96 | -$0.94 | -$0.83 | -$0.23 | -$0.27 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $121.6M | $84.6M | $107.3M | $76.3M | $93M | |
| Total Assets | $123.9M | $96.1M | $125.1M | $91.6M | $106.7M | |
| Current Liabilities | $5.8M | $11.2M | $12.9M | $14.1M | $15.7M | |
| Total Liabilities | $6.5M | $19M | $26.9M | $26.5M | $26.6M | |
| Total Equity | $117.4M | $77M | $98.2M | $65.1M | $80M | |
| Total Debt | $657K | $8M | $14.4M | $12.9M | $11.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$32.5M | -$67M | -$62.9M | -$13.2M | -$20.5M | |
| Cash From Investing | -$35.9M | $41.1M | -$27.6M | $17.9M | -$20.4M | |
| Cash From Financing | $61.1M | $27.1M | $85M | -$105K | $29.6M | |
| Free Cash Flow | -$37.8M | -$67.1M | -$63M | -$13.2M | -$20.5M | |
ATYR
Sector
Market Cap
$81.1M
$28.4M
Price % of 52-Week High
11.36%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-120.55%
-1.32%
1-Year Price Total Return
-75.14%
-22.19%
Beta (5-Year)
0.572
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.77
200-day SMA
Sell
Level
$3.37
Bollinger Bands (100)
Sell
Level
0.52 - 4.98
Chaikin Money Flow
Sell
Level
-295.1M
20-day SMA
Buy
Level
$0.74
Relative Strength Index (RSI14)
Sell
Level
48.41
ADX Line
Buy
Level
27.06
Williams %R
Sell
Level
-14.4809
50-day SMA
Sell
Level
$0.84
MACD (12, 26)
Sell
Level
-0.08
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
8.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.592)
Sell
CA Score
(Annual)
Level (-2.1911)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (4.6846)
Sell
Piotroski F Score
(Annual)
Level (2)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Stock Forecast FAQ
In the current month, ATYR has received 1 Buy ratings 7 Hold ratings, and 0 Sell ratings. The ATYR average analyst price target in the past 3 months is $4.36.
-
Where Will aTyr Pharma, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that aTyr Pharma, Inc. share price will rise to $4.36 per share over the next 12 months.
-
What Do Analysts Say About aTyr Pharma, Inc.?
Analysts are divided on their view about aTyr Pharma, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that aTyr Pharma, Inc. is a Sell and believe this share price will drop from its current level to $1.00.
-
What Is aTyr Pharma, Inc.'s Price Target?
The price target for aTyr Pharma, Inc. over the next 1-year time period is forecast to be $4.36 according to 8 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is ATYR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for aTyr Pharma, Inc. is a Hold. 7 of 8 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ATYR?
You can purchase shares of aTyr Pharma, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase aTyr Pharma, Inc. shares.
-
What Is The aTyr Pharma, Inc. Share Price Today?
aTyr Pharma, Inc. was last trading at $0.83 per share. This represents the most recent stock quote for aTyr Pharma, Inc.. Yesterday, aTyr Pharma, Inc. closed at $0.83 per share.
-
How To Buy aTyr Pharma, Inc. Stock Online?
In order to purchase aTyr Pharma, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get ATYR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ATYR
Sector
P/E ratio
--
23.66x
PEG ratio
--
-0.01x
P/B ratio
1.01x
1.84x
Price / LTM sales
388.29x
1.60x
Growth Metrics
ATYR
Sector
Revenue growth
--
4.85%
Earnings growth
-16.38%
11.15%
Revenue (5-year growth)
-11.05%
6.45%
Earnings forecast
-$0.19
-$0.20
Profitability
ATYR
Sector
Profitability FY 2024
-$1.3M
$3.6M
Return on invested capital
-87.48%
-30.98%
Return on assets
-75.87%
-27.62%
Return on equity
-103.05%
-36.69%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Mar
19
Estimated Next Earnings Date
Feb
5
Balance Sheet
ATYR
Sector
Total cash
$90.2M
$27.2M
Short term investments
$61.1M
$25.7M
Total assets
$98.1M
$79.9M
Long term debt
$11.6M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
44
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
